Wuhan National Bio-industry Base, also known as the Biolake, is China's second largest state-level biotech industrial base in view of overall strength, in Wuhan East Lake High-tech Development Zone -- also known as the Optics Valley of China -- located in China's Central Hubei province.
The construction of the Biolake in the city of Wuhan started in November 2008 and after 11 years of development the bioindustry has become one of the pillar industries of Optics Valley. To date, Optics Valley Biolake has attracted some 3,000 companies to locate there.
At present, Biolake's seven industrial parks have formed an industrial cluster characterized by biomedicines, bio medical engineering, bio agriculture, precision medicine, smart medicines and bio services.
Currently, 30 Class I new drugs -- those that have never been marketed in China or overseas – that were developed there have entered the clinical stage.
Officials said that more than 500 Class I and II medical devices, 59 new veterinary drugs and 69 State-approved new varieties of crops developed there have gone on the market -- and 149 products have entered the innovative products catalog of the city of Wuhan.